Chemically optimized stereopure oligonucleotides direct ADAR- mediated RNA editing Paloma H Giangrande, PhD Vice President, Platform Discovery Sciences Biology Oligonucleotides & Precision Therapeutics March 15-16, 2022 Forward looking statements 2 This document contains forward-looking statements. All statements other than statements of historical facts contained in this document, including statements regarding possible or assumed future results of operations, preclinical and clinical studies, business str ...